Fred Alger Management’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-17,955
Closed -$283K 567
2022
Q3
$283K Buy
+17,955
New +$283K ﹤0.01% 421